| GSK Highlights Immuno-Oncology Focus with Adaptimmune Collaboration |
Abstract
|
|
Heather Cartwright |
|
| Bayer Returns to Gene Therapy Arena with Dimension Therapeutics Deal |
Abstract
|
|
Heather Cartwright |
|
| Pfizer Makes Significant Entry into CAR-T Field with Cellectis Pact |
Abstract
|
|
Heather Cartwright |
|
| Synairgen Partners with AstraZeneca to Advance its Lead Asthma Programme |
Abstract
|
|
Heather Cartwright |
|
| Shire Licenses Hunter Syndrome Therapy from ArmaGen Technologies |
Abstract
|
|
Heather Cartwright |
|
| Teva Advances Pain Management Strategy with Labrys Biologics Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Merck & Co. Accelerates Development of All-Oral HCV Triple-Drug Regimen with Idenix Acquisition |
Abstract
Untitled
|
|
Heather Cartwright |
|
| Salix Joins the Tax Inversion Wave by Agreeing to Merge with Cosmo Pharmaceuticals’ Irish Unit |
Abstract
|
|
Heather Cartwright |
|